GWPH - Jefferies sees 46% upside in CareDx in premarket analyst action February, 15 2019 07:46 AM GW Pharmaceuticals Plc CareDx (NASDAQ:CDNA) initiated with Buy rating and $35 (46% upside) price target at Jefferies. More news on: CareDx, Inovalon, Revance Therapeutics, Inc., Healthcare stocks news, , Read more ...